coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Woking Wise 1 PCN, Woking · Health Inequalities Profile

    PCN U51357 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    30,205

    Registered population

    59.0% aged 18–64

    19.8%

    Aged 65+

    ICB 18.8% · England 17.9%

    25.8%

    Ethnic minority (non-White)

    20.1% Asian · England 9.6%

    0.6%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~107

    Core20 residents (est.)

    Resident basis; registered basis ~127 · see page 3

    4,389

    Hypertension register

    +5.75% in 3 yrs · England +5.60%

    197

    SMI register

    19.6% of Woking's

    357

    COPD register

    Reviews -0.37% in 3 yrs

    Forecast to 2030

    4,996

    Hypertension patients, 2030

    +607 on today

    78.8%

    QRISK ≥20% on statins, 2030

    +6.26pp over 3 yrs

    5.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -7.2%
    Heart failure and respiratory review trends lag England.

    Three-year changes trail England for heart failure (-7.2% vs +8.7%) and asthma reviews (-0.1% vs +4.4%; 562 unreviewed), which may reflect unverified recall capacity.

    72.3 pp
    Vaccination achievement and phone access vary across practices.

    QOF vaccination spans 72.3 pp (21.4% at The Practice College Road; 93.7% at St John's Family Practice), while easy phone contact spans 44.9 pp.

    77.2%
    Hypertension control and lipid therapy exceed England averages.

    Hypertension treated to target reaches 77.2% (England 70.3%; 3-year change +6.4% vs +3.6%), alongside 64.2% lipid therapy for QRISK ≥ 20% (England 63.6%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients aged 65+ reach 19.8% alongside a 20.1% Asian resident share

    Across 30,205 registered patients in four practices (ranging from 3,873 at The Practice College Road to 11,152 at St John's Family Practice), 19.8% (5,984) are aged 65+, exceeding Woking (15.3%), NHS Surrey Heartlands ICB (18.8%), and England (17.9%). Patients aged 0-17 comprise 21.2% (6,410). Based on Census usual residents rather than registered patients, 20.1% are Asian or Asian British—above Woking (14.2%), the ICB (7.7%), and England (9.6%)—concentrated at The Practice College Road (28.4%) versus Chobham & West End Medical Practice (4.9%). This older profile and ethnic diversity may shape chronic disease capacity and outreach, though unverified locally.

    Age profile

    0–1721.2%
    18–6459.0%
    65+19.8%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White74.2%
    Asian20.1%
    Other2.1%
    Mixed2.0%
    Black1.6%

    Older people · falls rows are Woking local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Woking LA)1,8542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)64.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Woking LA)7969819552024/25
    Falls deaths, all ages, per 100,000 (Woking LA)11.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 share is 0.6%, concentrated at The Practice College Road at 3.3%

    WOKING WISE 1 PCN averages IMD decile 8.0, compared with 7.8 in Woking, 7.9 in NHS Surrey Heartlands ICB, and 5.5 in England. Overall Core20 prevalence is 0.6%, below England (21.0%), Woking (1.5%), and the ICB (0.8%). Core20 patients concentrate entirely at The Practice College Road (3.3%, 127 estimated patients), with 0.0% across Chobham & West End Medical Practice, Pirbright Surgery, and St John's Family Practice. Weighted practice share (0.4%) differs from the PCN rate by 0.19 percentage points, while resident decile 1 and 2 estimates total 107.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    College Road3.3% · 127 patients
    Chobham & West0.0% · 0 patients
    St John's0.0% · 0 patients
    Pirbright0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    197

    SMI register

    0.64% recorded prevalence

    123

    Learning disability register

    0.40% recorded prevalence

    15

    Care homes, 591 beds

    In the PCN catchment

    8.3%

    Provide unpaid care

    Woking, Census 2021

    Recorded learning disability prevalence (0.4%, 123 patients) and severe mental illness (0.6%, 197 patients) trail Woking (0.5%; 0.8%), the ICB (0.5%; 0.8%), and England (0.6%; 1.0%). Catchment care homes provide 15 sites (591 beds). At borough level, Woking has an 8.3% unpaid care rate and recorded 6 rough sleepers in 2025. Clinical register audits would test whether lower recorded prevalence reflects demographic differences or unrecorded need.

    Severe mental illness: physical health checks

    SMI prevalence is 0.6% (197 patients; England 1.0%). Physical checks show 85.8% had blood pressure recorded and 82.6% BMI (England 83.4% and 82.1%), but alcohol status was 78.1% (England 81.8%), suggesting scope to complete full health checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,389

    Hypertension register

    +5.75%

    Register growth, 3 yrs

    Woking +6.51% · England +5.60%

    +4.36pp

    BP control, under 80

    ≤140/90 · +2.51pp aged 80+

    +607

    More patients by 2030

    Forecast 4,996 (16.03%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.3% (4,389 patients), above Woking (13.2%), matching NHS Surrey Heartlands Integrated Care Board (14.3%), and below England (15.2%), with an unadjusted benchmark gap range of -396 to +211 patients. Clinical control is high: 91.4% have a recent blood pressure reading (England 90.0%), and 77.2% are treated to target (England 70.3%), including 72.7% under age 80 (England 67.8%) and 89.1% aged 80 and over (England 81.2%). Over three years, patients treated to target rose +6.4% (England +3.6%). Although clinical control is strong, recorded prevalence below England indicates an opportunity to review opportunistic screening.

    Lipids and statins

    At 64.2%, patients with QRISK ≥ 20% receiving lipid-lowering therapy exceed England (63.6%), Woking (61.7%), and NHS Surrey Heartlands Integrated Care Board (59.4%), after a 3-year rise of +10.8% (England +6.2%). Treatment rates above all benchmarks show effective cardiovascular primary prevention to sustain.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202634,567£2.20£2.24£1.86£76,047
    Cardiovascular (all), 202544,666£4.57£4.74£3.33£204,124

    In 2026, 34,567 lipid-regulating items averaged £2.20 each (England £1.86, NHS Surrey Heartlands Integrated Care Board £2.24, Woking £2.50). This was £11,753 more than at England's unit cost, but £1,383 less than at NHS Surrey Heartlands Integrated Care Board unit cost. Higher unit spend than England indicates a potential formulary review opportunity.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.06%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +6.26%

    Asthma prevalence, PCN 3-yr % change

    The asthma register includes 1,738 patients (6.0% prevalence, England 6.6%), having grown +6.3% over three years (England +0.5%). Annual asthma reviews reached 67.7% (England 65.7%, Woking 68.1%), but three-year review change was -0.1% (England +4.4%), leaving 562 patients unreviewed as a scale indicator. COPD prevalence is 1.2% (357 patients; England 1.9%), with reviews at 81.5% (England 76.4%) despite a three-year change of -0.4% (England +2.8%). Stagnating review trends across growing registers suggest routine recall capacity may be constrained.

    Cancer register and children's immunisation

    The cancer register has 1,372 patients (4.5% prevalence, England 3.8%). Childhood immunisations achieve 94.9% for 6-in-1 at 12 months (England 91.0%), but coverage drops by age five: MMR dose 2 reaches 83.8% (below the 95.0% target by 11.2 pp; England 82.8%) and the 4-in-1 booster reaches 79.4% (below target by 15.6 pp; England 80.9%). Within the age-five cohort, MMR dose 2 trails MMR dose 1 (91.2%) by 7.4 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.9%

    England 91.0%

    6-in-1 complete primary course at 24 months94.0%

    England 92.2%

    MMR dose 1 at 24 months94.0%

    England 88.3%

    MMR dose 2 at age 583.8%

    England 82.8%

    4-in-1 pre-school booster at age 579.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In NHS Surrey Heartlands ICB, 61.4% of cancers with a known stage (2,955 of 4,810) were diagnosed at stage 1 or 2 in 2022, above England (55.3%) but 13.6 pp below the 75.0% national ambition by 2028 (about 650 extra cases needed). Known stage was recorded for 67.7% of registered cancers. Across WOKING WISE 1 PCN, cancer prevalence is 4.5% (1,372 patients), with a 3-year change of +9.9% (England +9.0%). Cervical screening (aged 25 to 49) reached 68.3% (England 66.8%), with a 3-year change of -2.6% (England -1.0%), while The Practice College Road recorded 47.5%. Declining screening uptake may delay early detection, warranting targeted recall at lower-uptake practices.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, provider Ashford and St Peter's Hospitals NHS Foundation Trust achieved 85.5% on the 28-day faster diagnosis standard (standard 75.0%), exceeding England (79.3%) and Royal Surrey NHS Foundation Trust (82.6%). On the 62-day standard, it reached 76.4% (standard 85.0%), trailing Royal Surrey NHS Foundation Trust (84.5%). For diagnostics, 49.6% of colonoscopy and 57.9% of flexi sigmoidoscopy patients waited 6+ weeks (England 30.8% and 32.1%; Royal Surrey NHS Foundation Trust 0.0% each). These provider figures describe system activity rather than PCN cohorts. Endoscopy delays at the provider could affect diagnostic resolution for lower gastrointestinal referrals.

    Pathways within standard (%)Ashford and St Peter'sRoyal SurreyFrimley HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5382.6287.9579.2979.32
    31-day treatment (96%)94.2196.4392.8990.4592.50
    62-day referral to treatment (85%)76.3884.4881.8471.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sRoyal SurreyFrimley HealthEngland
    MRI0.090.0012.8521.40
    CT9.270.150.639.92
    Echocardiography0.971.553.3528.48
    Colonoscopy49.610.0022.8430.83
    Gastroscopy56.740.007.4329.02
    All 15 DM01 tests23.128.827.4923.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026, community services recorded 109,530 contacts for Woking borough residents, with 76,215 involving adults aged 65+ (69.6% of all contacts). While these figures capture borough residents rather than PCN-registered patients, they reflect community healthcare use among older residents. Community contact volumes among older residents suggest scope to align PCN proactive reviews with local community teams.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Easy phone access spans 44.9 percentage points and vaccination achievement spans 72.3 percentage points

    Overall QOF achievement spans from 78.2% at Chobham & West End Medical Practice to 99.3% at St John's Family Practice (England 92.5%). Vaccination and immunisation achievement varies by 72.3 pp, from 21.4% at The Practice College Road to 93.7% at St John's Family Practice (England 55.2%). QOF points reflect incentive thresholds rather than unique patient coverage.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Pirbright Surgery1060.083.2%73.7%89.0%
    College Road963.376.9%83.5%82.4%
    St John's1250.045.2%78.3%74.1%
    Chobham & West1090.038.3%73.6%48.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWokingAssetPCNWoking
    Care homes (catchment)15 (591 beds)n/aSchools (catchment)69n/a
    Children's centres68Places of worship3249
    Librariesn/a1Homelessness support (VCS)0no data
    Day centres (VCS)22Carers support groups (VCS)11
    Primary schools (LA maintained)22Primary academies1819
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Respiratory annual review recall and case-finding

    Asthma reviews reached 67.7% (England 65.7%) after a -0.1% 3-year change (England +4.4%), leaving 562 of 1,738 patients unreviewed; COPD prevalence is 1.2% (357 patients vs England 1.9%, gap -2 to +215). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension case-finding and Core20 outreach

    Hypertension prevalence is 14.3% (4,389 patients), above Woking (13.2%) and matching the ICB (14.3%) but below England (15.2%), giving an unadjusted gap range of -396 to +211 patients. For discussion, the PCN could search for patients with uncoded raised blood pressure readings and offer opportunistic checks where Core20 patients concentrate. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Learning disability and heart failure validation

    Learning disability prevalence is 0.4% (123 patients vs England 0.6%; gap +26 to +55), while heart failure prevalence is 0.9% (281 patients vs England 1.1%; gap -4 to +51) and 3-year reviews fell 7.2% (England +8.7%). Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored outreach and communication (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Psychosis alcohol status review (p4)Patients with psychosis who have a current record of alcohol consumptionMHIS · From Harm to HopePCN
    Opportunistic blood pressure screening review (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall review (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice phone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Respiratory annual review recall and case-finding (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Hypertension case-finding and Core20 outreach (p12)Hypertension register · Hypertension: QOF prevalence · Asian / Asian BritishCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Learning disability and heart failure validation (p12)Learning disability register · Learning disability: QOF prevalence · Heart failure register75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15